12/03/2026
Ozone therapy, often administered as Major Autohemotherapy (AHT), shows potential to reduce HbA1c levels in type 2 diabetes patients by improving blood glucose control, enhancing tissue oxygenation, and reducing insulin resistance. Studies indicate it can lower HbA1c (e.g., from 9.4 to 5.8 in specific cases) by increasing glucose metabolism and reducing oxidative stress.